Search results
...Establish Joint Venture Company for Incubation of Early Drug Discovery Programs...OTC:ALPMY),...
Benzinga· 3 days agoTakeda Pharmaceutical Company Limited TAK President and CEO, Christophe Weber, ", Takeda", ))), Astellas...signed a master agreement on April 22, 2024, ...
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical...
Morningstar· 14 hours ago...or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), along with the Centre for Human Drug Research (CHDR), will present its Phase 1 stroke study...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 12 hours agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap ...
Cidara Therapeutics shares surge 30% after reacquiring flu treatment
Morningstar· 3 hours agoShares of Cidara Therapeutics (CDTX) rose sharply after the company announced a reshuffling of its portfolio of drug candidates. The biotechnology
Earnings call: Kiniksa Pharmaceuticals sees 85% revenue surge in Q1 2024 By Investing.com
Investing.com· 13 hours agoKiniksa Pharmaceuticals (NASDAQ:KNSA) has reported a significant increase in its financial...
Does Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands?
Investor's Business Daily· 12 hours agoTop-notch biotech stock Neurocrine Biosciences surged Tuesday after analysts suggested the company's...
Merck to Report Earnings One Month After Major Drug Approval. What Investors Are Watching.
Barrons.com· 6 hours agoFEATURE Merck is set to announce its first quarter financial results on Thursday, a month after the ...
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in...
NBC 10 - FOX 14 Monroe· 1 day agoPharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism ...
McKinsey Is Under Criminal Investigation for Its Opioid Work
New York Times· 3 hours agoFederal prosecutors are examining the consulting company’s role in helping “turbocharge” the sale of...
Arrowhead begins trial for kidney disease treatment By Investing.com
Investing.com· 7 hours agoArrowhead Pharmaceuticals, Inc. (NASDAQ: NASDAQ:ARWR) has initiated a Phase 1/2a clinical trial of...